Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Drug News & Perspectives
|
December 24, 2004
Update on antiobesity drugs
C A Wilson, D Cavalla
Journal of Neurochemistry
|
March 1, 1985
Photoaffinity labeling of the GABAA receptor with [3H]muscimol
D Cavalla, N H Neff
Biochemical Pharmacology
|
August 15, 1985
Chemical mechanisms for photoaffinity labeling of receptors
D Cavalla, N H Neff
European Journal of Pharmacology
|
August 7, 1986
Epinephrine synthesis in the PC12 pheochromocytoma cell line
J C Byrd, M Hadjiconstantinou, D Cavalla
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1985
Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit
W J Wojcik, D Cavalla, N H Neff
Drug News & Perspectives
|
August 26, 2003
The role of mitochondria in apoptosis
A M Palmer, P M Greengrass, D Cavalla, et al.
Cell Biochemistry and Biophysics
|
March 27, 1998
Correlations of PDE-4 inhibition between enzymes of smooth muscle and inflammatory cell sources
P Cariuk, D Cavalla, M Chasin, et al.
Neuropharmacology
|
June 1, 1985
Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridinium ion (MPP+) decrease dopamine and increase acetylcholine in the mouse neostriatum
D Cavalla, M Hadjiconstantinou, H E Laird, et al.
Journal of Neurochemistry
|
December 1, 1985
N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases acetylcholine and decreases dopamine in mouse striatum: both responses are blocked by anticholinergic drugs
M Hadjiconstantinou, D Cavalla, E Anthoupoulou, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Drug News & Perspectives
|
December 24, 2004
Update on antiobesity drugs
C A Wilson, D Cavalla
Journal of Neurochemistry
|
March 1, 1985
Photoaffinity labeling of the GABAA receptor with [3H]muscimol
D Cavalla, N H Neff
Biochemical Pharmacology
|
August 15, 1985
Chemical mechanisms for photoaffinity labeling of receptors
D Cavalla, N H Neff
European Journal of Pharmacology
|
August 7, 1986
Epinephrine synthesis in the PC12 pheochromocytoma cell line
J C Byrd, M Hadjiconstantinou, D Cavalla
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1985
Co-localized adenosine A1 and gamma-aminobutyric acid B (GABAB) receptors of cerebellum may share a common adenylate cyclase catalytic unit
W J Wojcik, D Cavalla, N H Neff
Drug News & Perspectives
|
August 26, 2003
The role of mitochondria in apoptosis
A M Palmer, P M Greengrass, D Cavalla, et al.
Cell Biochemistry and Biophysics
|
March 27, 1998
Correlations of PDE-4 inhibition between enzymes of smooth muscle and inflammatory cell sources
P Cariuk, D Cavalla, M Chasin, et al.
Neuropharmacology
|
June 1, 1985
Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridinium ion (MPP+) decrease dopamine and increase acetylcholine in the mouse neostriatum
D Cavalla, M Hadjiconstantinou, H E Laird, et al.
Journal of Neurochemistry
|
December 1, 1985
N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases acetylcholine and decreases dopamine in mouse striatum: both responses are blocked by anticholinergic drugs
M Hadjiconstantinou, D Cavalla, E Anthoupoulou, et al.
Page
of 2